Related Experiment Video
Updated: Feb 27, 2026

MicroRNA Expression Profiles of Human iPS Cells, Retinal Pigment Epithelium Derived From iPS, and Fetal Retinal Pigment Epithelium
Published on: June 24, 2014
Identification of pterygium-related mRNA expression profiling by microarray analysis
1Department of Ophthalmology, Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
Abstract:
PurposePterygium is a common degenerative and proliferative disease of the ocular surface. In some severe cases, pterygium may lead to irregular corneal astigmatism and corneal stromal scarring with visual impairment. The proliferative capacities of pterygial cells make them appear similar to tumorigenesis. Although considerable progress has been made towards understanding the etiology of the disease, the pathogenesis of pterygium has not been completely understood. In our previous study, we constructed pterygium-related lncRNA libraries by using microarray to investigate the potential roles of lncRNAs in pterygium. In this study, our objective was to explore the role of mRNA in pterygium.Patients and methodsIn this study, we constructed pterygium-related mRNA libraries by using microarray to investigate the potential roles of mRNAs in pterygium. Quantitative real-time PCR (qRT-PCR) was performed to validate some of the deregulated mRNAs in 10 patients.ResultsA total of 1485 upregulated and 2978 downregulated mRNAs were identified in pterygium tissues compared with paired adjacent normal conjunctival tissues (log fold change>2.0). qRT-PCR was performed to validate four overregulated and two underregulated mRNAs in 10 patients.ConclusionsOur results reveal differentially expressed mRNAs in pterygium and suggest that mRNAs may be the novel molecular targets for therapy of pterygium.
Insights
This study identified numerous differentially expressed messenger RNAs (mRNAs) in pterygium tissues, revealing their potential role in this ocular surface disease. These findings suggest mRNAs could be new therapeutic targets for pterygium treatment.
Area of Science:
- Ophthalmology
- Molecular Biology
- Genomics
Background:
- Pterygium is a degenerative ocular surface disease with proliferative characteristics, sometimes leading to visual impairment.
- Its pathogenesis remains incompletely understood despite similarities to tumorigenesis.
- Previous research explored long non-coding RNAs (lncRNAs) in pterygium.
Purpose of the Study:
- To investigate the potential roles of messenger RNAs (mRNAs) in pterygium pathogenesis.
- To identify differentially expressed mRNAs in pterygium tissues.
Main Methods:
- Construction of pterygium-related mRNA libraries using microarray analysis.
- Validation of selected deregulated mRNAs via quantitative real-time PCR (qRT-PCR) in 10 patients.
Main Results:
- Identification of 1485 upregulated and 2978 downregulated mRNAs in pterygium tissues compared to normal conjunctiva.
- qRT-PCR confirmed the differential expression of four upregulated and two downregulated mRNAs.
Conclusions:
- The study reveals distinct mRNA expression profiles in pterygium.
- These differentially expressed mRNAs represent potential novel molecular targets for pterygium therapy.

